Skip to Content
Merck
  • Short-term effects of cilazapril and atenolol on P-wave dispersion in patients with hypertension.

Short-term effects of cilazapril and atenolol on P-wave dispersion in patients with hypertension.

Advances in therapy (2008-02-26)
Mustafa Tuncer, Yilmaz Gunes, Unal Guntekin, Hasan Ali Gumrukcuoglu, Beyhan Eryonucu
ABSTRACT

P-wave dispersion (PWD) has been shown to be a non-invasive electrocardiographic predictor for development of atrial fibrillation (AF). Thus, it may be possible to decrease AF risk through improvement in PWD. Our objective was to compare the effects of cilazapril and atenolol on P-wave duration and dispersion in patients with hypertension. A total of 38 newly diagnosed hypertensive patients were enrolled in the study. The patients were randomly assigned to receive treatment with either cilazapril (5 mg) or atenolol (50 mg). Doppler echocardiographic examination, P-wave durations and PWD were measured before and 1 mo after treatment Both drugs reduced blood pressure significantly (P<0.001). Posttreatment heart rate was significantly lower in the atenolol group (P=0.01). The change in maximum P-wave duration was not significant. However, both agents decreased PWD (P=0.001 and P<0.001) and increased the minimum P-wave duration (P=0.004 and P=0.02). Both cilazapril and atenolol treatments resulted in improvement in PWD.

MATERIALS
Product Number
Brand
Product Description

Cilazapril, European Pharmacopoeia (EP) Reference Standard
Cilazapril impurity D, European Pharmacopoeia (EP) Reference Standard